Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of ...

Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

"This is a very clear effort to shine a light on this anti-vaccine trope: that thimerosal is somehow dangerous.” ...

Flu vaccines contain tiny amounts of the viruses that the vaccine protects against. In the shot, these viruses are inactivated, or dead, so they cannot cause the flu.

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...